Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: N06BC01

Gencebok(Caffeine citrate)

Apnea

Marketing Authorisation Holder: Gennisium Pharma

EMA Authorisation: 19/08/2020

INN: caffeine citrate

Indication

Treatment of primary apnoea of premature newborns.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Gencebok — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.